Today, CSAM Health Group AS (CSAM) presented its financial results for the fourth quarter of 2020 during a shareholder webcast.
Sverre Flatby, CEO discussed highlights from the fourth quarter, including the acquisition of Fertsoft AB, as well as the Q1 2021 acquisition of Carmenta’s Public Safety business. Einar Bonnevie, CFO presented a detailed overview of the financial results for Q4 and the full year 2020 preliminary.
Today, CSAM Health Group AS (CSAM) published its financial report for the fourth quarter of 2020.
Report highlights include:
CSAM Health Group AS (CSAM) will release results for the fourth quarter of 2020 on Friday, February 26th at 08:00 CET on https://newsweb.oslobors.no and www.csamhealth.com/investor-relations.
A presentation of the results, including a discussion of CSAM’s two recent acquisitions – Fertsoft AB and Carmenta Public Safety AB – will be given by Sverre Flatby,
CSAM Health Group AS (“CSAM”), the leading provider of niche eHealth solutions in the Nordics, today announced that they have acquired the Public Safety business of Carmenta Holding AB of Sweden.
With the acquisition of Carmenta Public Safety, CSAM expands its Emergency & Acute offering across the Nordics and Europe, further strengthening its leading position in this key domain.
Reference is made to the announcement from CSAM Health Group AS (“CSAM”) on 18 December 2020 regarding the agreed acquisition of all shares in Fertsoft AB (“Fertsoft”). Today, CSAM successfully completed the acquisition of all shares in Fertsoft.
The purchase price for the shares will be settled through an issue of 62,247 new CSAM shares to the shareholders of Fertsoft,
CSAM Health Group AS (“CSAM”), the leading provider of niche eHealth solutions in the Nordics, today announced that they have entered into a Share Purchase Agreement for the acquisition of all shares in Fertsoft AB (“Fertsoft”).
With the acquisition of Fertsoft, CSAM has created a comprehensive portfolio of women and children’s healthcare solutions – ranging from conception to early childhood – and further strengthened its position.
Today, CSAM Health Group AS (CSAM) presented its financial results for the third quarter of 2020 during a shareholder webcast.
Sverre Flatby, CEO provided an overview of the company’s strategy as well as highlights from the third quarter. Einar Bonnevie, CFO presented a detailed overview of the financial results for Q3 and the first nine months of 2020.
Today, CSAM Health Group AS (CSAM) published its financial report for the third quarter of 2020.
Report highlights include:
• Q3 2020 sales of MNOK 52 367, representing growth of 4%
• Q3 2020 recurring revenue of 42 903 MNOK, representing growth of 3%
• Increased EBITDA margin – from 26% in Q3 2019 to 31% in Q3 2020
• Successful inaugural bond issue of 300 million NOK
• Preparations to go public on the Oslo Stock Exchange,
CSAM Health Group AS (CSAM) will release results for the third quarter of 2020 on Friday, November 27th at 08:00 CET on https://newsweb.oslobors.no and www.csamhealth.com.
A presentation of the results will be given by Sverre Flatby, CEO and Einar Bonnevie, CFO, at 08:30 CET via webcast, which can be accessed at www.csamhealth.com/investor-relations.
Technological advancements have been a driving force behind many significant improvements in healthcare, increasing access to services, enhancing efficiency and quality of care, and empowering patients to take control of their health.
Some of the most impressive impacts of technology in healthcare have come from the highly specialised software that enables the daily workflows of healthcare professionals.